Amanote Research
Register
Sign In
Cardiac Fibrosis and Dysfunction in Experimental Diabetic Cardiomyopathy Are Ameliorated by Alpha-Lipoic Acid
Cardiovascular Diabetology
- United Kingdom
doi 10.1186/1475-2840-11-73
Full Text
Open PDF
Abstract
Available in
full text
Categories
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
Date
January 1, 2012
Authors
Chun-jun Li
Lin Lv
Hui Li
De-min Yu
Publisher
Springer Science and Business Media LLC
Related search
Alpha-Lipoic Acid and Diabetic Neuropathy
Review of Diabetic Studies
Internal Medicine
Endocrinology
Metabolism
Diabetes
Alpha-Lipoic Acid in Non-Proliferative Diabetic Retinopathy Treatment
Diabetes Mellitus
Internal Medicine
Endocrinology
Metabolism
Diabetes
Alpha-Lipoic Acid in the Treatment of Diabetic Polyneuropathy
Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova
Psychiatry
Mental Health
Neurology
Mitochondrial Dysfunction and Alpha-Lipoic Acid: Beneficial or Harmful in Alzheimer’s Disease?
Oxidative Medicine and Cellular Longevity
Biochemistry
Medicine
Cell Biology
Aging
Protective Effects of Irbesartan and Alpha Lipoic Acid in STZ-induced Diabetic Nephropathy in Rats
Renal Failure
Medicine
Nephrology
Critical Care
Intensive Care Medicine
Effect of Thiamine Repletion on Cardiac Fibrosis and Protein O-Glycosylation in Diabetic Cardiomyopathy
J Diabetes Metab
Inhibition of PKC-θ Preserves Cardiac Function and Reduces Fibrosis in Streptozotocin-Induced Diabetic Cardiomyopathy
British Journal of Pharmacology
Pharmacology
Ursodeoxycholic Acid Ameliorated Diabetic Nephropathy by Attenuating Hyperglycemia-Mediated Oxidative Stress
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Alpha Lipoic Acid Combined With Epalrestat: A Therapeutic Option for Patients With Diabetic Peripheral Neuropathy
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science